# Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus

> **NCT06820060** · — · ACTIVE_NOT_RECRUITING · sponsor: **QIAGEN Gaithersburg, Inc** · enrollment: 1500 (estimated)

## Conditions studied

- Meningitis
- Encephalitis Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06820060
- **Lead sponsor:** QIAGEN Gaithersburg, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-03
- **Primary completion:** 2026-01-15
- **Final completion:** 2026-05
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06820060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06820060, "Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06820060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*